Transplant Donor SiteTissue DonorsKidney TransplantationLiving DonorsGraft SurvivalGraft RejectionImmunosuppressive AgentsTissue and Organ ProcurementCadaverTransplantation, HomologousKidneyDirected Tissue DonationHistocompatibility TestingWaiting ListsHistocompatibilityTransplantsTreatment OutcomeBone Marrow TransplantationGraft vs Host DiseaseKidney Failure, ChronicRetrospective StudiesTransplantationTacrolimusTime FactorsKidney DiseasesAntilymphocyte SerumHematopoietic Stem Cell TransplantationCyclosporineMycophenolic AcidUnrelated DonorsHeart TransplantationTransplantation ConditioningImmunosuppressionBK VirusRisk FactorsSurvival RateDelayed Graft FunctionPostoperative ComplicationsLung TransplantationWhole-Body IrradiationPolyomavirus InfectionsBlood DonorsSurvival AnalysisPancreas TransplantationCreatinineKidney Function TestsIsoantibodiesCytomegalovirus InfectionsGlomerular Filtration RateFollow-Up StudiesKidney TubulesTransplantation ImmunologyHLA AntigensBiopsyImmunocompromised HostRenal DialysisAcute Kidney InjuryPrimary Graft DysfunctionProspective StudiesBrain DeathIranSirolimusCalcineurinIncidenceFetal Tissue TransplantationComplement C4bRenal InsufficiencyKidney CortexCohort StudiesDonor SelectionProportional Hazards ModelsNephrectomyDrug Therapy, CombinationCytomegalovirusTransplantation ToleranceBiological MarkersLiver FailureBlood Group IncompatibilityKaplan-Meier EstimateRecurrenceKidney GlomerulusRisk AssessmentAcute DiseaseDrug MonitoringPrognosisRegistriesGingival HypertrophyGanciclovirKidney NeoplasmsDeathPostoperative PeriodUreteral DiseasesMultivariate AnalysisTissue and Organ HarvestingLymphoproliferative DisordersKidney Tubular Necrosis, AcuteUnited StatesLiver TransplantationChronic DiseaseAzathioprine